Vaxcyte Inc

PCVXNASDAQ · USD
60.50USD+1.73 (+2.95%)
2210

Vaxcyte Inc (PCVX) Implied Volatility Current

PCVX implied volatility is 96%. IV Rank is 90%, placing current premiums in the top of their 52-week range.

Read more

Tracking PCVX implied volatility helps you identify when options premiums on Vaxcyte Inc are historically cheap or expensive, and where the best trades are hiding. Vaxcyte Inc implied volatility reflects the market's expectation of future price movement: when PCVX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Vaxcyte Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PCVX, tracking metrics like PCVX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PCVX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis.

The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PCVX implied volatility sits today versus where it has been. Our scanner ranks Vaxcyte Inc implied volatility against its historical range, surfaces extremes in PCVX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Vaxcyte Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
89.68%IV Rank
High

IV is near its yearly peak - premiums are expensive, favoring sellers.

Implied Volatility (30d)95.70%

IV Rank89.68%

Historical Volatility (30d)32.01%

IV - HV+63.69%

As of September 16, 2026

Trade options with IV on your side

Track PCVX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial